scholarly journals Characteristics of Chronic Noncancer Pain Patients Assessed with the Opioid Risk Tool in a Canadian Tertiary Care Pain Clinic

Pain Medicine ◽  
2014 ◽  
Vol 15 (10) ◽  
pp. 1743-1749 ◽  
Author(s):  
Shehnaz Fatima Lakha ◽  
Ada F. Louffat ◽  
Keith Nicholson ◽  
Amol Deshpande ◽  
Angela Mailis-Gagnon
2019 ◽  
Vol 20 (3) ◽  
pp. 222-231 ◽  
Author(s):  
Yukari Shindo ◽  
Soushi Iwasaki ◽  
Michiaki Yamakage

2007 ◽  
Vol 12 (2) ◽  
pp. 93-99 ◽  
Author(s):  
Angela Mailis-Gagnon ◽  
Balaji Yegneswaran ◽  
SF Lakha ◽  
Keith Nicholson ◽  
Amanda J Steiman ◽  
...  

BACKGROUND: Pain clinics tend to see more complex chronic pain patients than primary care settings, but the types of patients seen may differ among practices.OBJECTIVE: The aim of the present observational study was to describe the pain and demographic characteristics of patients attending a university-affiliated tertiary care pain clinic in Toronto, Ontario.METHODS: Data were collected on 1242 consecutive new patients seen over a three-year period at the Comprehensive Pain Program in central Toronto.RESULTS: Musculoskeletal problems affecting large joints and the spine were the predominant cause of pain (more prevalent in women), followed by neuropathic disorders (more prevalent in men) in patients with recognizable physical pathology. The most affected age group was in the 35- to 49-year age range, with a mean pain duration of 7.8 years before the consultation. While 77% of the Comprehensive Pain Program patients had relevant and detectable physical pathology for pain complaints, three-quarters of the overall study population also had significant associated psychological or psychiatric comorbidity. Women, in general, attended the pain clinic in greater numbers and had less apparent physical pathology than men. Finally, less than one in five patients was employed at the time of referral.CONCLUSIONS: The relevance of the data in relation to other pain clinics is discussed, as well as waiting lists and other barriers faced by chronic pain patients, pain practitioners and pain facilities in Ontario and Canada.


2017 ◽  
Vol Volume 10 ◽  
pp. 1713-1722 ◽  
Author(s):  
Pamela Landsman-Blumberg ◽  
Nathaniel Katz ◽  
Kavita Gajria ◽  
Anna D’Souza ◽  
Sham L Chaudhari ◽  
...  

2007 ◽  
Vol 105 (5) ◽  
pp. 1442-1448 ◽  
Author(s):  
Oguzhan Dagtekin ◽  
Hans J. Gerbershagen ◽  
Werner Wagner ◽  
Frank Petzke ◽  
Lukas Radbruch ◽  
...  

2004 ◽  
Vol 37 (4) ◽  
pp. 191-192 ◽  
Author(s):  
M. Soyka ◽  
M. Backmund ◽  
S. Hasemann

2006 ◽  
Vol 2 (6) ◽  
pp. 347 ◽  
Author(s):  
Steve Simon, MD, RPh ◽  
Daniel S. Bennett, MD ◽  
Richard Rauck, MD ◽  
Donald Taylor, MD ◽  
Steven Shoemaker, MD

Objective: This report aims to describe the prevalence and characteristics of breakthrough pain in patients with neuropathic pain.Methods: The study represents data from a subset of patients from a larger survey of 228 patients with chronic noncancer pain. Patients were identified from nine pain programs and were administered a telephone questionnaire. The study population comprised 45 chronic noncancer pain patients with primary neuropathic pain diagnoses who were being treated with opioids.Results: Pain had been present for a median of six years. Medications used for pain in addition to opioids included nonsteroidal anti-inflammatory agents (29 percent), antidepressants (60 percent), and anticonvulsants (53 percent). Thirty-five of the patients (78 percent) described a total of 42 distinct types of breakthrough pain. The median number of episodes per day was two; the median time to maximum intensity was 10 minutes, and the median duration of pain was 60 minutes. Patients could identify a precipitant for 62 percent of the pains, and 88 percent of the precipitants were activity related. The onset of breakthrough pain could not be predicted for 48 percent of the pains and could only sometimes be predicted for 29 percent of the pains.Conclusion: Breakthrough pain is common in opioidtreated patients with chronic neuropathic pain. Such pain often has a rapid onset and a relatively short duration, and it is frequently difficult to predict, similar to breakthrough pain in cancer patients.


Pain Medicine ◽  
2011 ◽  
Vol 12 (10) ◽  
pp. 1481-1489 ◽  
Author(s):  
I. Elias Veizi ◽  
Salim M. Hayek ◽  
Samer Narouze ◽  
Jason E. Pope ◽  
Nagy Mekhail

Sign in / Sign up

Export Citation Format

Share Document